Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 347.64%14.85M | 347.64%14.85M | -57.38%2.04M | -34.20%3.02M | -55.38%2.38M | -52.82%3.32M | -52.82%3.32M | -51.10%4.79M | -40.35%4.59M | -53.03%5.33M |
-Cash and cash equivalents | 347.64%14.85M | 347.64%14.85M | -57.38%2.04M | -34.20%3.02M | -55.38%2.38M | -52.82%3.32M | -52.82%3.32M | -51.10%4.79M | -40.35%4.59M | -53.03%5.33M |
Prepaid assets | 97.47%1.67M | 97.47%1.67M | -49.86%222.59K | -1.57%580.63K | -30.09%792.84K | -36.54%844.94K | -36.54%844.94K | -57.95%443.97K | -55.30%589.88K | -2.53%1.13M |
Other current assets | 686.91%28.01K | 686.91%28.01K | 10.72%20.84K | 9.23%35.07K | -3.11%52.24K | -51.19%3.56K | -51.19%3.56K | 37.62%18.82K | 26.53%32.11K | 58.23%53.92K |
Total current assets | 297.18%16.54M | 297.18%16.54M | -56.50%2.28M | -30.24%3.64M | -50.55%3.22M | -50.23%4.17M | -50.23%4.17M | -51.66%5.25M | -42.34%5.21M | -48.04%6.52M |
Non current assets | ||||||||||
Net PPE | --222.65K | --222.65K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
-Gross PPE | --224.22K | --224.22K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
-Accumulated depreciation | ---1.58K | ---1.58K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Goodwill and other intangible assets | --77.52M | --77.52M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
-Goodwill | --11.81M | --11.81M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
-Other intangible assets | --65.71M | --65.71M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Non current prepaid assets | --18.13K | --18.13K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Total non current assets | --77.76M | --77.76M | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Total assets | 2,164.06%94.31M | 2,164.06%94.31M | -56.50%2.28M | -30.24%3.64M | -50.55%3.22M | -50.23%4.17M | -50.23%4.17M | -51.66%5.25M | -42.34%5.21M | -48.04%6.52M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 1,000.68%1.23M | 1,000.68%1.23M | 121.53%454.96K | 1.61%217.76K | 45.65%196.76K | -80.47%111.91K | -80.47%111.91K | -69.77%205.37K | -67.80%214.31K | -59.15%135.09K |
-accounts payable | 1,000.68%1.23M | 1,000.68%1.23M | 121.53%454.96K | 1.61%217.76K | 45.65%196.76K | -80.47%111.91K | -80.47%111.91K | -69.77%205.37K | -67.80%214.31K | -59.15%135.09K |
Current accrued expenses | 369.34%1.16M | 369.34%1.16M | 274.02%878.86K | -6.83%226.39K | -12.99%279.35K | -20.54%246.64K | -20.54%246.64K | -66.06%234.98K | -72.56%242.99K | -75.49%321.05K |
Current debt and capital lease obligation | --49.7K | --49.7K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Current capital lease obligation | --49.7K | --49.7K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Current liabilities | 785.89%3.18M | 785.89%3.18M | 173.80%1.33M | -3.84%500.08K | 3.79%570.08K | -65.63%358.55K | -65.63%358.55K | -70.17%487.14K | -72.60%520.03K | -70.74%549.29K |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | --15.54M | --15.54M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
-Long term debt | --15.38M | --15.38M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Long term capital lease obligation | --154.89K | --154.89K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Non current deferred liabilities | --11.31M | --11.31M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Total non current liabilities | --26.85M | --26.85M | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Total liabilities | 8,274.67%30.03M | 8,274.67%30.03M | 173.80%1.33M | -3.84%500.08K | 3.79%570.08K | -65.63%358.55K | -65.63%358.55K | -70.17%487.14K | -72.60%520.03K | -70.74%549.29K |
Shareholders'equity | ||||||||||
Share capital | 96,630,412.99%74.41M | 96,630,412.99%74.41M | -94.24%111 | 49.17%2.78K | 5.07%1.93K | -95.80%77 | -95.80%77 | 5.07%1.93K | 123.41%1.86K | 120.05%1.83K |
-common stock | 72.73%133 | 72.73%133 | -94.24%111 | 49.17%2.78K | 5.07%1.93K | -95.80%77 | -95.80%77 | 5.07%1.93K | 123.41%1.86K | 120.05%1.83K |
-Preferred stock | --74.41M | --74.41M | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | -20.09%-73.82M | -20.09%-73.82M | -9.48%-66.09M | -7.91%-63.81M | -8.79%-62.76M | -9.43%-61.47M | -9.43%-61.47M | -11.52%-60.37M | -14.70%-59.13M | -20.47%-57.69M |
Paid-in capital | 3.48%67.86M | 3.48%67.86M | 2.93%67.34M | 4.88%67.24M | 3.22%65.71M | 3.27%65.58M | 3.27%65.58M | 3.27%65.42M | 9.23%64.11M | 8.71%63.66M |
Less: Treasury stock | 0.00%299.13K | 0.00%299.13K | 0.01%299.13K | 2.35%299.11K | --299.11K | --299.13K | --299.13K | --299.11K | --292.24K | ---- |
Gains losses not affecting retained earnings | ---3.86M | ---3.86M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Total stockholders'equity | 1,588.54%64.28M | 1,588.54%64.28M | -80.06%949.43K | -33.17%3.14M | -55.55%2.65M | -48.04%3.81M | -48.04%3.81M | -48.38%4.76M | -34.31%4.69M | -44.05%5.97M |
Total equity | 1,588.54%64.28M | 1,588.54%64.28M | -80.06%949.43K | -33.17%3.14M | -55.55%2.65M | -48.04%3.81M | -48.04%3.81M | -48.38%4.76M | -34.31%4.69M | -44.05%5.97M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |